It is appropriate to evaluate at-risk male relatives of an affected individual in order to identify as early as possible those who would benefit from institution of treatment and preventive measures.

If the RS1 pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.

If the pathogenic variant in the family is not known, examination by an ophthalmologist can be used to clarify the affected status of at-risk relatives for early treatment of retinal detachment.

See Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes.
